Publications in collaboration with researchers from Universidade de São Paulo (17)

2024

  1. Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia

    Blood, Vol. 144, Núm. 12, pp. 1257-1270

2023

  1. Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

    British Journal of Haematology, Vol. 200, Núm. 2, pp. 170-174

2021

  1. Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants

    Blood Cancer Journal

2020

  1. NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

    Scientific Reports, Vol. 10, Núm. 1

  2. Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic Leukemia

    Cancers, Vol. 12, Núm. 11, pp. 1-16

2019

  1. Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia

    Blood, Vol. 134, Núm. 12, pp. 951-959

  2. Management of acute promyelocytic leukemia: Updated recommendations from an expert panel of the European LeukemiaNet

    Blood, Vol. 133, Núm. 15, pp. 1630-1643

2018

  1. The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia

    British Journal of Haematology

2017

  1. Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia

    Blood Advances, Vol. 1, Núm. 21, pp. 1807-1814

2015

  1. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: A matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

    Annals of Hematology, Vol. 94, Núm. 8, pp. 1347-1356

  2. High Δnp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia

    Blood, Vol. 126, Núm. 20, pp. 2302-2306

2014

  1. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study

    Annals of Hematology, Vol. 93, Núm. 12, pp. 2001-2010

  2. Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: An International Consortium on Acute Promyelocytic Leukaemia study

    British Journal of Haematology, Vol. 166, Núm. 4, pp. 540-549

2013

  1. Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

    Blood, Vol. 121, Núm. 11, pp. 1935-1943

2012

  1. Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT

    Leukemia, Vol. 26, Núm. 6, pp. 1211-1217

  2. The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL)

    Hematology, Vol. 17, Núm. SUPPL. 1

2003

  1. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow

    Blood, Vol. 102, Núm. 8, pp. 3043-3051